SEC Comment Letter 0000000000-25-000729 to RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772) (RAPT)
RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772)
Date: Jan. 23, 2025 · CIK: 0001673772 · Accession: 0000000000-25-000729
AI Filing Summary & Sentiment
File numbers found in text: 333-284388
Letter
January 23, 2025 Brian Wong President and Chief Executive Officer RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco, CA 94080 Re:RAPT Therapeutics, Inc. Registration Statement on Form S-3 Filed January 21, 2025 File No. 333-284388 Dear Brian Wong: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Courtney Tygesson
Show Raw Text
January 23, 2025
Brian Wong
President and Chief Executive Officer
RAPT Therapeutics, Inc.
561 Eccles Avenue
South San Francisco, CA 94080
Re:RAPT Therapeutics, Inc.
Registration Statement on Form S-3
Filed January 21, 2025
File No. 333-284388
Dear Brian Wong:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Courtney Tygesson